• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: HEART VALVES SANTA ANA HANCOCK II AORTIC BIOPROSTHETIC HEART VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

HEART VALVES SANTA ANA HANCOCK II AORTIC BIOPROSTHETIC HEART VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number T505
Medical Device Problem Codes Device Operates Differently Than Expected (2913); Insufficient Device Problem Information (3190)
Health Effect - Clinical Codes Aortic Insufficiency (1715); Aortic Valve Stenosis (1717); Dyspnea (1816); No Information (3190)
Date of Event 02/02/2017
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Without the return of the product, no definitive conclusion can be made regarding the clinical observation.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event or Problem Description
Medtronic received information that 2 years 2 months post implant of this bioprosthetic aortic valve, this device was replaced, valv e-in-valve with a transcatheter bioprosthetic valve.No failure mechanism and no other adverse patient effects were reported.
 
Additional Manufacturer Narrative
Medtronic received additional information that this device was replaced due to severe aortic stenosis and moderate insufficiency.Prior to the replacement procedure, the patient presented with functional class iv (b)(6) symptoms, including chest pain and shortness of breath on exertion.The patient was in stable condition following replacement, and nothing out of the ordinary occurred.Patient's weight added.Patient's relevant medical history added.(b)(4).
 
Additional Manufacturer Narrative
A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HANCOCK II AORTIC BIOPROSTHETIC HEART VALVE
Common Device Name
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
HEART VALVES SANTA ANA
1851 e deere ave
santa ana CA 92705
MDR Report Key6347670
Report Number2025587-2017-00282
Device Sequence Number744310
Product Code LWR
UDI-Device Identifier00643169000438
UDI-Public00643169000438
Combination Product (Y/N)N
Initial Reporter StateTX
Initial Reporter CountryUS
PMA/510(K) Number
P980043
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2014
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date (Section B) 03/10/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date08/21/2017
Device Model NumberT505
Device Catalogue NumberT505U223
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 02/02/2017
Supplement Date Received by ManufacturerNot provided
03/10/2017
Initial Report FDA Received Date02/21/2017
Supplement Report FDA Received Date03/10/2017
09/29/2017
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age33 YR
Patient Weight77
-
-